Oncology - European Medical Journal

This site is intended for healthcare professionals

Continue

Oncology

Filter
13 Mins
22 Jun 2026

Poor-Prognosis uHCC: An Expert Perspective

Understand how poor-prognosis features may impact clinical decision-making in patients with unresectable hepatocellular carcinoma…
11 Jun 2026

HRD Testing in Advanced Ovarian Cancer

Explore how HRD testing can help identify patients with HRD-positive advanced ovarian cancer who are eligible for certain targeted therapies.
8 Jun 2026

HRRm Testing in mCRPC

Homologous recombination repair gene-mutated (HRRm) biomarker testing is important to plan future treatment decisions in certain patients…
3 Mins
29 May 2026

What Can ARASEC Teach Us About Future Prostate Cancer Trials?

Darolutamide in combination with androgen deprivation therapy (ADT) is approved by the FDA for the treatment of metastatic hormone-sensitive…
20 Apr 2026

An FDA Approval for Certain Patients with Endometrial Cancer
9 Mins
29 Jan 2026

NMIBC Highlights from ESMO 2025

The therapeutic landscape in non-muscle-invasive bladder cancer (NMIBC) is advancing with the investigation of new treatment…
11 Mins
22 Jan 2026

HER+ eBC Highlights from SABCS 2025

Treatment of early breast cancer (eBC) is continuing to advance, and pivotal Phase III trial data released at the San Antonio Breast…
10 Mins
19 Dec 2025

Updates in Early-Stage HER2+ Breast Cancer

Data presented at the European Society for Medical Oncology (ESMO) Congress 2025 signal a potential shift in the management of early-stage…
We’ve noticed you’re accessing
from North/South America.